Postdoctoral scholar Dayan Elshan (Jung group) won first place in the cancer category for his poster at the UCLA Biomedical and Life Science Innovation Day 2018.
Elshan received a $750 prize for his poster titled “Androgen Receptor Degraders and Signaling Axis Inhibitors Targeting Castration-Resistant Prostate Cancer”. At the June 13th event held at the Luskin Center, UCLA researchers from all over the campus presented over 125 posters, highlighting their ground-breaking work, grouped according to the UCLA unified research themes.
The UCLA Biomedical & Life Science Innovation Day 2018 organized by the UCLA Technology Development Group (TDG), is intended to promote awareness of the growing life science entrepreneurial ecosystem at UCLA and to foster partnerships with the biotechnology and life science industry.
In front of his award winning poster, Dr. Dayan Elshan with his mentor Prof. Michael Jung.
Elshan received his B.Sc. degree in Chemistry from the University of Colombo (Sri Lanka) in 2008 with first class honors. He conducted his doctoral research on the multivalent targeting of melanocortin and cholecystokinin receptors under the guidance of Prof. Eugene A. Mash at the University of Arizona and obtained his Ph.D. degree in 2014. In 2015, he joined UCLA as a postdoctoral scholar working with Prof. Michael E. Jung and Prof. Matthew B. Rettig, to develop novel prostate cancer therapies that function by targeting the androgen receptor transactivation domain.
Elshan recently spearheaded the Jung group’s sustainability efforts by obtaining a The Green Initiative Fund (TGIF) grant to successfully adopt the use of waterless condensers in their organic synthesis work.
Photo courtesy of Prof. Michael Jung.
